hat’s it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?

We tackle all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Tune in for a recap of the lively chat about capitalism we had on Wednesday, a dive into the latest CAR-T upheaval, and a discussion of how the FDA’s quote-unquote flexibility might be a little more rigid than biotech thought. Also we talk about Grindr.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I have my podcast from Apple; it has not worked for me with STAT. Is there another podcast forum that Boston Globe STAT could recommend?

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.